News | January 20, 2022
SEC recommends regular market approval for Covishield and Covaxin
However, these won’t be available at the nearest chemist store soon
However, these won’t be available at the nearest chemist store soon
The company will receive an upfront payment as well as regulatory and sales based milestone payments from Lotus
Ram’s appointment follows the launch of the CDI India division in October 2021.
He holds nine US patents and has published in multiple peer-reviewed journals and conferences
The company has 47 ANDA's pending approval with the U.S.FDA
The company has 271 cumulative ANDA filings with USFDA of which 243 ANDAs have been approved and 28 are pending approval
Market data indicates that more than twenty percent of the new chemical entities being developed use roller compaction technology in their development and commercialization
Their strong recommendation is based on moderate certainty evidence that it improves survival and reduces the need for ventilation
Chicago based virtual reality company reaches AIIMS, assisting in surgical planning and training
New data from ongoing trial showed increased antibody response against Beta, Delta, Alpha, Gamma and Omicron variants following third dose booster with Vaxzevria
Subscribe To Our Newsletter & Stay Updated
